case report | Q2782326 |
scholarly article | Q13442814 |
P2093 | author name string | Roxann Rokey | |
Sreelatha Chalasani | |||
Satya S. Bhupathi | |||
P2860 | cites work | ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...] | Q22306349 |
Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management | Q24531062 | ||
Cardiac amyloidosis--an update | Q28211315 | ||
Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents | Q28235210 | ||
Dialysis-related amyloidosis of the heart in long-term hemodialysis patients | Q31905886 | ||
Amyloidosis: review of 236 cases | Q33146750 | ||
Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens | Q33508070 | ||
Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation | Q34154414 | ||
Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis | Q34176563 | ||
Cardiac amyloidosis. | Q34267191 | ||
Diagnosis and management of the cardiac amyloidoses | Q34454122 | ||
Unique type of isolated cardiac valvular amyloidosis | Q35126862 | ||
Amyloid in the cardiovascular system: a review | Q35588349 | ||
The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies | Q35640323 | ||
Antibody-mediated resolution of light chain-associated amyloid deposits. | Q35745765 | ||
Managing systemic light-chain amyloidosis | Q36750316 | ||
Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation | Q36825014 | ||
Cardiac amyloidosis in a patient with multiple myeloma: a case report and review of literature. | Q37379828 | ||
How I treat amyloidosis | Q37555858 | ||
The clinical and biochemical spectrum of hereditary amyloidosis | Q39284517 | ||
Diagnosis and treatment of primary amyloidosis | Q40402468 | ||
Ocular amyloidosis | Q40738100 | ||
Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management | Q41513063 | ||
The systemic amyloidoses | Q41596634 | ||
Five or more years of survival in patients with primary systemic amyloidosis and biopsy-proven cardiac involvement | Q43520391 | ||
Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins | Q44022591 | ||
Comparison of gastroduodenal, renal and abdominal fat biopsies for diagnosing amyloidosis in rheumatoid arthritis | Q44042670 | ||
Clinical outcome and survival of secondary (AA) amyloidosis. | Q44503338 | ||
Systolic and diastolic ventricular function in cardiac amyloidosis. Studies in six cases diagnosed with endomyocardial biopsy | Q44538393 | ||
Current treatment in cardiac amyloidosis | Q46141603 | ||
Diagnostic accuracy of subcutaneous abdominal fat tissue aspiration for detecting systemic amyloidosis and its utility in clinical practice | Q46406608 | ||
Peripheral nerve amyloidosis in sural nerve biopsies: a clinicopathologic analysis of 13 cases | Q46638134 | ||
Evaluation of abdominal fat pad aspiration cytology and grading for detection in systemic amyloidosis. | Q46851509 | ||
Diagnosis and immunohistochemical classification of systemic amyloidoses. Report of 43 cases in an unselected autopsy series | Q47733990 | ||
Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress | Q47882082 | ||
Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival | Q47914422 | ||
Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy | Q48031970 | ||
Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients. | Q54129778 | ||
Digoxin sensitivity in amyloid cardiomyopathy | Q67299816 | ||
Survival of patients with primary (AL) amyloidosis. Colchicine-treated cases from 1976 to 1983 compared with cases seen in previous years (1961 to 1973) | Q69106102 | ||
Isolated cardiac amyloidosis associated with sudden death | Q69609873 | ||
Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosis | Q71015688 | ||
Cardiac amyloidosis causing cardiac dysfunction: analysis of 54 necropsy patients | Q71755587 | ||
[Characteristic features of the heart disease in the elderly] | Q72528437 | ||
The diagnosis and typing of cardiac amyloidosis | Q73920614 | ||
Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients | Q74511292 | ||
The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement | Q74524530 | ||
Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts | Q74582113 | ||
Amyloidosis | Q77061406 | ||
Atrial thrombosis in cardiac amyloidosis: diagnostic contribution of transesophageal echocardiography | Q77846870 | ||
Diagnosing primary amyloidosis | Q78650274 | ||
Rectal biopsy for the diagnosis of amyloidosis | Q79244157 | ||
Noninvasive diagnosis of biopsy-proven cardiac amyloidosis | Q79761534 | ||
Diagnosis of cardiac amyloidosis based on the myocardial velocity profile in the hypertrophied left ventricular wall | Q79838317 | ||
Endomyocardial biopsy plays a role in diagnosing patients with unexplained cardiomyopathy | Q80060767 | ||
Patterns of isolated atrial amyloid: a study of 100 hearts on autopsy | Q80273155 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 92-99 | |
P577 | publication date | 2010-09-17 | |
P1433 | published in | Clinical Medicine & Research | Q15757811 |
P1476 | title | Stiff heart syndrome | |
Stiff Heart Syndrome | |||
P478 | volume | 9 |